Back to search
SMARCB1-Deficient Malignancies
Clinical trial pipeline · Data from ClinicalTrials.gov
See which SMARCB1-Deficient Malignancies trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which SMARCB1-Deficient Malignancies trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
To find out if ubamatamab, given by itself or in combination with cemiplimab, can help to control the disease in participants with renal medullary carcinoma (RM…
This phase I/II trial studies how well tiragolumab and atezolizumab works when given to children and adults with SMARCB1 or SMARCA4 deficient tumors that have e…
This research study involves a combination of three drugs given together as a possible treatment for malignant rhabdoid tumor, atypical teratoid rhabdoid tumor,…